NHMRC Australian Genome Health Alliance

Bioplatforms Australia invests in the Australian Genome Health Alliance (AGHA) that brings together more than 50 partner organisations committed to integrating genomic medicine into healthcare across Australia.

Our involvement lends the Bioplatforms Australia research infrastructure to this critical national research agenda.

The programme aims to shorten diagnosis times, enable early intervention and provide access to treatment for people with genetic disorders. The research will develop the knowledge to translate genomic technology into clinical practice so patients and their families benefit.

The Alliance began meeting in 2014 as a group committed to improving access to genomic healthcare, and has since expanded to include organisations from all around Australia and overseas – our members include clinical genetics services, research institutes, public pathology laboratories, hospitals, universities, professional bodies and patient advocacy groups.

In 2015, the AGHA was awarded a $25 million grant from the National Health and Medical Research Council’s (NHMRC) Targeted Call for Research into Preparing Australia for the Genomics Revolution in Healthcare.

Over the course of this five-year grant, the AGHA will make Australia a global leader in genomic medicine by providing the best evidence and policy advice to the Government, state agencies, hospitals and health providers. By seamlessly and sustainably integrating this technology into our healthcare system, all Australians will benefit.